Search

Your search keyword '"Erten, Sukran"' showing total 200 results
Start Over Author "Erten, Sukran"
200 results on '"Erten, Sukran"'

1. Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry

Author

Triggianese, Paola, Vitale, Antonio, Lopalco, Giuseppe, Mayrink Giardini, Henrique Ayres, Ciccia, Francesco, Al-Maghlouth, Ibrahim, Ruscitti, Piero, Sfikakis, Petros Paul, Iannone, Florenzo, de Brito Antonelli, Isabele Parente, Patrone, Martina, Asfina, Kazi Nur, Di Cola, Ilenia, Laskari, Katerina, Gaggiano, Carla, Tufan, Abdurrahman, Sfriso, Paolo, Dagna, Lorenzo, Giacomelli, Roberto, Hinojosa-Azaola, Andrea, Ragab, Gaafar, Fotis, Lampros, Direskeneli, Haner, Spedicato, Veronica, Dagostin, Marilia Ambiel, Iacono, Daniela, Ali, Hebatallah Hamed, Cipriani, Paola, Sota, Jurgen, Kardas, Riza Can, Bindoli, Sara, Campochiaro, Corrado, Navarini, Luca, Gentileschi, Stefano, Martín-Nares, Eduardo, Torres-Ruiz, Jiram, Saad, Moustafa Ali, Kourtesi, Katerina, Alibaz-Oner, Fatma, Sevik, Gizem, Iagnocco, Annamaria, Makowska, Joanna, Govoni, Marcello, Monti, Sara, Maggio, Maria Cristina, La Torre, Francesco, Del Giudice, Emanuela, Hernández-Rodríguez, José, Bartoloni, Elena, Emmi, Giacomo, Chimenti, Maria Sole, Maier, Armin, Simonini, Gabriele, Conti, Giovanni, Olivieri, Alma Nunzia, Tarsia, Maria, De Paulis, Amato, Lo Gullo, Alberto, Więsik-Szewczyk, Ewa, Viapiana, Ombretta, Ogunjimi, Benson, Tharwat, Samar, Erten, Sukran, Nuzzolese, Rossana, Karamanakos, Anastasios, Frassi, Micol, Conforti, Alessandro, Caggiano, Valeria, Marino, Achille, Sebastiani, Gian Domenico, Gidaro, Antonio, Tombetti, Enrico, Carubbi, Francesco, Rubegni, Giovanni, Cartocci, Alessandra, Balistreri, Alberto, Fabiani, Claudia, Frediani, Bruno, and Cantarini, Luca

Published
2024
Full Text
View/download PDF

2. Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry

Author

Triggianese, Paola, Vitale, Antonio, Lopalco, Giuseppe, Mayrink Giardini, Henrique Ayres, Ciccia, Francesco, Al-Maghlouth, Ibrahim, Ruscitti, Piero, Sfikakis, Petros Paul, Iannone, Florenzo, de Brito Antonelli, Isabele Parente, Patrone, Martina, Asfina, Kazi Nur, Di Cola, Ilenia, Laskari, Katerina, Gaggiano, Carla, Tufan, Abdurrahman, Sfriso, Paolo, Dagna, Lorenzo, Giacomelli, Roberto, Hinojosa-Azaola, Andrea, Ragab, Gaafar, Fotis, Lampros, Direskeneli, Haner, Spedicato, Veronica, Dagostin, Marilia Ambiel, Iacono, Daniela, Ali, Hebatallah Hamed, Cipriani, Paola, Sota, Jurgen, Kardas, Riza Can, Bindoli, Sara, Campochiaro, Corrado, Navarini, Luca, Gentileschi, Stefano, Martín-Nares, Eduardo, Torres-Ruiz, Jiram, Saad, Moustafa Ali, Kourtesi, Katerina, Alibaz-Oner, Fatma, Sevik, Gizem, Iagnocco, Annamaria, Makowska, Joanna, Govoni, Marcello, Monti, Sara, Maggio, Maria Cristina, La Torre, Francesco, Del Giudice, Emanuela, Hernández-Rodríguez, José, Bartoloni, Elena, Emmi, Giacomo, Chimenti, Maria Sole, Maier, Armin, Simonini, Gabriele, Conti, Giovanni, Olivieri, Alma Nunzia, Tarsia, Maria, De Paulis, Amato, Lo Gullo, Alberto, Więsik-Szewczyk, Ewa, Viapiana, Ombretta, Ogunjimi, Benson, Tharwat, Samar, Erten, Sukran, Nuzzolese, Rossana, Karamanakos, Anastasios, Frassi, Micol, Conforti, Alessandro, Caggiano, Valeria, Marino, Achille, Sebastiani, Gian Domenico, Gidaro, Antonio, Tombetti, Enrico, Carubbi, Francesco, Rubegni, Giovanni, Cartocci, Alessandra, Balistreri, Alberto, Fabiani, Claudia, Frediani, Bruno, and Cantarini, Luca

Published
2023
Full Text
View/download PDF

3. Development and implementation of the AIDA International Registry for patients with Behçet’s disease

Author

Vitale, Antonio, Della Casa, Francesca, Ragab, Gaafar, Almaghlouth, Ibrahim A., Lopalco, Giuseppe, Pereira, Rosa Maria, Guerriero, Silvana, Govoni, Marcello, Sfikakis, Petros P., Giacomelli, Roberto, Ciccia, Francesco, Monti, Sara, Ruscitti, Piero, Piga, Matteo, Lomater, Claudia, Tufan, Abdurrahman, Opris-Belinski, Daniela, Emmi, Giacomo, Hernández-Rodríguez, José, Şahin, Ali, Sebastiani, Gian Domenico, Bartoloni, Elena, Akkoç, Nurullah, Gündüz, Özgül Soysal, Cattalini, Marco, Conti, Giovanni, Hatemi, Gulen, Maier, Armin, Parronchi, Paola, Del Giudice, Emanuela, Erten, Sukran, Insalaco, Antonella, Li Gobbi, Francesca, Maggio, Maria Cristina, Shahram, Farhad, Caggiano, Valeria, Hegazy, Mohamed Tharwat, Asfina, Kazi Nur, Morrone, Maria, Prado, Leandro L., Dammacco, Rosanna, Ruffilli, Francesca, Arida, Aikaterini, Navarini, Luca, Pantano, Ilenia, Cavagna, Lorenzo, Conforti, Alessandro, Cauli, Alberto, Marucco, Elena Maria, Kucuk, Hamit, Ionescu, Ruxandra, Mattioli, Irene, Espinosa, Gerard, Araújo, Olga, Karkaş, Burak, Canofari, Claudia, Sota, Jurgen, Laymouna, Ahmed Hatem, Bedaiwi, Asma. A., Colella, Sergio, Giardini, Henrique Ayres M., Albano, Valeria, Lo Monaco, Andrea, Fragoulis, George E., Kardas, Riza Can, Berlengiero, Virginia, Hussein, Mohamed A., Ricci, Francesca, La Torre, Francesco, Rigante, Donato, Więsik-Szewczyk, Ewa, Frassi, Micol, Gentileschi, Stefano, Tosi, Gian Marco, Dagostin, Marilia Ambiel, Mahmoud, Ayman Abdel-Monem Ahmed, Tarsia, Maria, Alessio, Giovanni, Cimaz, Rolando, Giani, Teresa, Gaggiano, Carla, Iannone, Florenzo, Cipriani, Paola, Mourabi, Mariam, Spedicato, Veronica, Barneschi, Sara, Aragona, Emma, Balistreri, Alberto, Frediani, Bruno, Fabiani, Claudia, and Cantarini, Luca

Published
2022
Full Text
View/download PDF

4. Clinical and molecular evaluation of MEFV gene variants in the Turkish population: a study by the National Genetics Consortium

Author

Dundar, Munis, Fahrioglu, Umut, Yildiz, Saliha Handan, Bakir-Gungor, Burcu, Temel, Sehime Gulsun, Akin, Haluk, Artan, Sevilhan, Cora, Tulin, Sahin, Feride Iffet, Dursun, Ahmet, Sezer, Ozlem, Gurkan, Hakan, Erdogan, Murat, Gunduz, C. Nur Semerci, Bisgin, Atil, Ozdemir, Ozturk, Ulgenalp, Ayfer, Percin, E. Ferda, Yildirim, Malik Ejder, Tekes, Selahaddin, Bagis, Haydar, Yuce, Huseyin, Duman, Nilgun, Bozkurt, Gokay, Yararbas, Kanay, Yildirim, Mahmut Selman, Arman, Ahmet, Mihci, Ercan, Eraslan, Serpil, Altintas, Zuhal Mert, Aymelek, Huri Sema, Ruhi, Hatice Ilgin, Tatar, Abdulgani, Ergoren, Mahmut Cerkez, Cetin, G. Ozan, Altunoglu, Umut, Caglayan, Ahmet Okay, Yuksel, Berrin, Ozkul, Yusuf, Saatci, Cetin, Kenanoglu, Sercan, Karasu, Nilgun, Dundar, Bilge, Ozcelik, Firat, Demir, Mikail, Siniksaran, Betul Seyhan, Kulak, Hande, Kiranatlioglu, Kubra, Baysal, Kubra, Kazimli, Ulviyya, Akalin, Hilal, Dundar, Ayca, Boz, Mehmet, Bayram, Arslan, Subasioglu, Asli, Colak, Fatma Kurt, Karaduman, Neslihan, Gunes, Meltem Cerrah, Kandemir, Nefise, Aynekin, Busra, Emekli, Rabia, Sahin, Izem Olcay, Ozdemir, Sevda Yesim, Onal, Muge Gulcihan, Senel, Abdurrahman Soner, Poyrazoglu, Muammer Hakan, Kisaarslan, Ayse Nur Pac, Gursoy, Sebnem, Baskol, Mevlut, Calis, Mustafa, Demir, Huseyin, Zararsiz, Gozde Erturk, Erdogan, Mujgan Ozdemir, Elmas, Muhsin, Solak, Mustafa, Ulu, Memnune Sena, Thahir, Adam, Aydin, Zafer, Atasever, Umut, Sag, Sebnem Ozemri, Aliyeva, Lamiya, Alemdar, Adem, Dogan, Berkcan, Erguzeloglu, Cemre Ornek, Kaya, Niyazi, Ozkinay, Ferda, Cogulu, Ozgur, Durmaz, Asude, Onay, Huseyin, Karaca, Emin, Durmaz, Burak, Aykut, Ayca, Cilingir, Oguz, Aras, Beyhan Durak, Gokalp, Ebru Erzurumluoglu, Arslan, Serap, Temena, Arda, Haziyeva, Konul, Kocagil, Sinem, Bas, Hasan, Susam, Ezgi, Keklikci, Ali Riza, Sarac, Elif, Kocak, Nadir, Nergiz, Suleyman, Terzi, Yunus Kasim, Dincer, Selin Akad, Baskin, Esra Sidika, Genc, Gunes Cakmak, Bahadir, Oguzhan, Sanri, Aslihan, Yigit, Serbulent, Tozkir, Hilmi, Yalcintepe, Sinem, Ozkayin, Nese, Kiraz, Aslihan, Balta, Burhan, Gonen, Gizem Akinci, Kurt, E. Emre, Ceylan, Gulay Gulec, Ceylan, Ahmet Cevdet, Erten, Sukran, Bozdogan, Sevcan Tug, Boga, Ibrahim, Yilmaz, Mustafa, Silan, Fatma, Kocabey, Mehmet, Koc, Altug, Cankaya, Tufan, Bora, Elcin, Bozkaya, Ozlem Giray, Ercal, Derya, Ergun, Mehmet Ali, Ergun, Sezen Guntekin, Duman, Yesim Sidar, Beyazit, Serife Busra, Uzel, Veysiye Hulya, Em, Serda, Cevik, Muhammer Ozgur, Eroz, Recep, Demirtas, Mercan, Firat, Cem Koray, Kabayegit, Zehra Manav, Altan, Mustafa, Mardan, Lamiya, Sayar, Ceyhan, Tumer, Sait, Turkgenc, Burcu, Karakoyun, Hilal Keskin, Tunc, Betul, Kuru, Seda, Zamani, Aysegul, Geckinli, Bilgen Bilge, Ates, Esra Arslan, Clark, Ozden Altiok, Toylu, Asli, Coskun, Mert, Nur, Banu, Bilge, Ilmay, Bayramicli, Oya Uygur, Emmungil, Hakan, Komesli, Zeynep, Zeybel, Mujdat, Gurakan, Figen, Tasdemir, Mehmet, Kebudi, Rejin, Karabulut, Halil Gurhan, Tuncali, Timur, Kutlay, Nuket Yurur, Kahraman, Cigdem Yuce, Onder, Nerin Bahceciler, Beyitler, Ilke, Kavukcu, Salih, Tulay, Pinar, Tosun, Ozgur, Tuncel, Gulten, Mocan, Gamze, Kale, Hamdi, Uyguner, Zehra Oya, Acar, Aynur, Altinay, Mert, and Erdem, Levent

Published
2022
Full Text
View/download PDF

6. Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor:results from 13 European registries

Author

Linde, Louise, Ørnbjerg, Lykke M., Georgiadis, Stylianos, Rasmussen, Simon H., Lindström, Ulf, Askling, Johan, Michelsen, Brigitte, Di Giuseppe, Daniela, Wallman, Johan K., Gudbjornsson, Bjorn, Love, Thorvardur Jon, Nordström, Dan C., Yli-Kerttula, Timo, Nekvindová, Lucie, Vencovský, Jiří, Iannone, Florenzo, Cauli, Alberto, Loft, Anne Gitte, Glintborg, Bente, Laas, Karin, Rotar, Ziga, Tomšič, Matija, MacFarlane, Gary J., Möller, Burkhard, Van De Sande, Marleen, Codreanu, Catalin, Nissen, Michael J., Birlik, Merih, Erten, Sukran, Santos, Maria J., Vieira-Sousa, Elsa, Hetland, Merete L., Østergaard, Mikkel, Linde, Louise, Ørnbjerg, Lykke M., Georgiadis, Stylianos, Rasmussen, Simon H., Lindström, Ulf, Askling, Johan, Michelsen, Brigitte, Di Giuseppe, Daniela, Wallman, Johan K., Gudbjornsson, Bjorn, Love, Thorvardur Jon, Nordström, Dan C., Yli-Kerttula, Timo, Nekvindová, Lucie, Vencovský, Jiří, Iannone, Florenzo, Cauli, Alberto, Loft, Anne Gitte, Glintborg, Bente, Laas, Karin, Rotar, Ziga, Tomšič, Matija, MacFarlane, Gary J., Möller, Burkhard, Van De Sande, Marleen, Codreanu, Catalin, Nissen, Michael J., Birlik, Merih, Erten, Sukran, Santos, Maria J., Vieira-Sousa, Elsa, Hetland, Merete L., and Østergaard, Mikkel

Abstract

Objectives In bio-naïve patients with PsA initiating a TNF inhibitor (TNFi), we aimed to identify baseline predictors of Disease Activity index for PsA in 28 joints (DAPSA28) remission (primary objective) and DAPSA28 moderate response at 6 months, as well as drug retention at 12 months across 13 European registries. Methods Baseline demographic and clinical characteristics were retrieved and the three outcomes investigated per registry and in pooled data, using logistic regression analyses on multiply imputed data. In the pooled cohort, selected predictors that were either consistently positive or negative across all three outcomes were defined as common predictors. Results In the pooled cohort (n = 13 369), 6-month proportions of remission, moderate response and 12-month drug retention were 25%, 34% and 63% in patients with available data (n = 6954, n = 5275 and n = 13 369, respectively). Five common baseline predictors of remission, moderate response and 12-month drug retention were identified across all three outcomes. The odds ratios (95% CIs) for DAPSA28 remission were: age, per year: 0.97 (0.96–0.98); disease duration, years (<2 years as reference): 2–3 years: 1.20 (0.89–1.60), 4–9 years: 1.42 (1.09–1.84), ≥10 years: 1.66 (1.26–2.20); men vs women: 1.85 (1.54–2.23); CRP of >10 vs ≤10 mg/l: 1.52 (1.22–1.89) and 1 mm increase in patient fatigue score: 0.99 (0.98–0.99). Conclusion Baseline predictors of remission, response and adherence to TNFi therapy were identified, of which five were common for all three outcomes, indicating that the predictors emerging from our pooled cohort may be considered generalizable from country level to disease level., Objectives: In bio-naïve patients with PsA initiating a TNF inhibitor (TNFi), we aimed to identify baseline predictors of Disease Activity index for PsA in 28 joints (DAPSA28) remission (primary objective) and DAPSA28 moderate response at 6 months, as well as drug retention at 12 months across 13 European registries. Methods: Baseline demographic and clinical characteristics were retrieved and the three outcomes investigated per registry and in pooled data, using logistic regression analyses on multiply imputed data. In the pooled cohort, selected predictors that were either consistently positive or negative across all three outcomes were defined as common predictors. Results: In the pooled cohort (n=13 369), 6-month proportions of remission, moderate response and 12-month drug retention were 25%, 34% and 63% in patients with available data (n=6954, n=5275 and n=13 369, respectively). Five common baseline predictors of remission, moderate response and 12-month drug retention were identified across all three outcomes. The odds ratios (95% CIs) for DAPSA28 remission were: age, per year: 0.97 (0.96-0.98); disease duration, years (<2 years as reference): 2-3 years: 1.20 (0.89-1.60), 4-9 years: 1.42 (1.09-1.84), ≥10 years: 1.66 (1.26-2.20); men vs women: 1.85 (1.54-2.23); CRP of >10 vs ≤10 mg/l: 1.52 (1.22-1.89) and 1mm increase in patient fatigue score: 0.99 (0.98-0.99). Conclusion: Baseline predictors of remission, response and adherence to TNFi therapy were identified, of which five were common for all three outcomes, indicating that the predictors emerging from our pooled cohort may be considered generalizable from country level to disease level.

Published
2024

7. Baseline capillaroscopy provides no evidence of microvascular changes to predict long-COVID syndrome.

Author

OZDEMIR ULUSOY, Bahar, BABAOGLU, Hakan, ARMAGAN, Berkan, AYPAK ALTUNSOY, Adalet, AKINCI, Esragul, KUCUKSAHIN, Orhan, OMMA, Ahmet, ERTEN, Sukran, and ERDEN, Abdulsamet

Subjects
POST-acute COVID-19 syndrome, COVID-19, COVID-19 testing, COVID-19 pandemic, CAPILLAROSCOPY
Abstract

BACKGROUND: Long-COVID refers to a variety of symptoms that continue for at least 4 weeks following the onset of acute COVID-19 infection. "Microclots/microvasculopathy" is a potential cutting-edge theory. Nailfold capillaroscopy is a non-invasive method used to assess microvascularity. In this study, we aimed to compare baseline characteristics and capillaroscopic findings of patients with and without long-COVID syndrome. METHODS: Baseline clinical characteristics of 53 patients who tested positive for SARS-CoV-2 were recorded. At the time of COVID-19 diagnosis, patients underwent nailfold capillaroscopy. One year later, patients were rescreened for long-COVID symptoms. Comparisons were made between patients with and without long-COVID syndrome in terms of their baseline characteristics and capillaroscopic findings. RESULTS: There were 35 individuals (66%) with long-COVID syndrome. The most common symptoms related to long-COVID were fatigue (43.4%), myalgia (34%), arthralgia (20.8%), dyspnea (20.8%). In total, 22 patients (41.5%) had abnormal capillaroscopy findings. Like other baseline characteristics, the proportion of patients with abnormal capillaroscopic findings (40% vs 44%, p=0.76) was similar between patients with and without long-COVID syndrome. CONCLUSION: Microvasculopathy and microthrombotic vascular damage are among the strongest hypotheses discussed in this regard. Our results may suggest that factors, rather than baseline microvasculopathy, may drive pathophysiological mechanism underlying the poorly understood long-COVID syndrome [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry

Author

Triggianese, Paola, primary, Vitale, Antonio, additional, Lopalco, Giuseppe, additional, Mayrink Giardini, Henrique Ayres, additional, Ciccia, Francesco, additional, Al-Maghlouth, Ibrahim, additional, Ruscitti, Piero, additional, Sfikakis, Petros Paul, additional, Iannone, Florenzo, additional, de Brito Antonelli, Isabele Parente, additional, Patrone, Martina, additional, Asfina, Kazi Nur, additional, Di Cola, Ilenia, additional, Laskari, Katerina, additional, Gaggiano, Carla, additional, Tufan, Abdurrahman, additional, Sfriso, Paolo, additional, Dagna, Lorenzo, additional, Giacomelli, Roberto, additional, Hinojosa-Azaola, Andrea, additional, Ragab, Gaafar, additional, Fotis, Lampros, additional, Direskeneli, Haner, additional, Spedicato, Veronica, additional, Dagostin, Marilia Ambiel, additional, Iacono, Daniela, additional, Ali, Hebatallah Hamed, additional, Cipriani, Paola, additional, Sota, Jurgen, additional, Kardas, Riza Can, additional, Bindoli, Sara, additional, Campochiaro, Corrado, additional, Navarini, Luca, additional, Gentileschi, Stefano, additional, Martín-Nares, Eduardo, additional, Torres-Ruiz, Jiram, additional, Saad, Moustafa Ali, additional, Kourtesi, Katerina, additional, Alibaz-Oner, Fatma, additional, Sevik, Gizem, additional, Iagnocco, Annamaria, additional, Makowska, Joanna, additional, Govoni, Marcello, additional, Monti, Sara, additional, Maggio, Maria Cristina, additional, La Torre, Francesco, additional, Del Giudice, Emanuela, additional, Hernández-Rodríguez, José, additional, Bartoloni, Elena, additional, Emmi, Giacomo, additional, Chimenti, Maria Sole, additional, Maier, Armin, additional, Simonini, Gabriele, additional, Conti, Giovanni, additional, Olivieri, Alma Nunzia, additional, Tarsia, Maria, additional, De Paulis, Amato, additional, Lo Gullo, Alberto, additional, Więsik-Szewczyk, Ewa, additional, Viapiana, Ombretta, additional, Ogunjimi, Benson, additional, Tharwat, Samar, additional, Erten, Sukran, additional, Nuzzolese, Rossana, additional, Karamanakos, Anastasios, additional, Frassi, Micol, additional, Conforti, Alessandro, additional, Caggiano, Valeria, additional, Marino, Achille, additional, Sebastiani, Gian Domenico, additional, Gidaro, Antonio, additional, Tombetti, Enrico, additional, Carubbi, Francesco, additional, Rubegni, Giovanni, additional, Cartocci, Alessandra, additional, Balistreri, Alberto, additional, Fabiani, Claudia, additional, Frediani, Bruno, additional, and Cantarini, Luca, additional

Published
2023
Full Text
View/download PDF

10. Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry

Author

Ruscitti, Piero, primary, Masedu, Francesco, additional, Vitale, Antonio, additional, Di Cola, Ilenia, additional, Caggiano, Valeria, additional, Di Muzio, Claudia, additional, Cipriani, Paola, additional, Valenti, Marco, additional, Berardicurti, Onorina, additional, Navarini, Luca, additional, Iacono, Daniela, additional, Pantano, Ilenia, additional, Mauro, Daniele, additional, Ciccia, Francesco, additional, Rossi, Silvia, additional, De Stefano, Ludovico, additional, Monti, Sara, additional, Bugatti, Serena, additional, Montecucco, Carlomaurizio, additional, Caso, Francesco, additional, Costa, Luisa, additional, Prete, Marcella, additional, Perosa, Federico, additional, Iagnocco, Annamaria, additional, Atzeni, Fabiola, additional, Guggino, Giuliana, additional, Giardini, Henrique, additional, Antonelli, Isabele Parente de Brito, additional, Almaghlouth, Ibrahim A, additional, Asfina, Kazi, additional, Direskeneli, Haner, additional, Alibaz-Oner, Fatma, additional, Sevik, Gizem, additional, Tufan, Abdurrahman, additional, Sfikakis, Petros P, additional, La Torre, Francesco, additional, Hinojosa-Azaola, Andrea, additional, Martín-Nares, Eduardo, additional, Torres-Ruiz, Jiram, additional, Ragab, Gafaar, additional, Maggio, Maria Cristina, additional, Makowska, Joanna, additional, Del Giudice, Emanuela, additional, Bartoloni, Elena, additional, Emmi, Giacomo, additional, Govoni, Marcello, additional, Lo Gullo, Alberto, additional, Lopalco, Giuseppe, additional, Simonini, Gabriele, additional, Fotis, Lampros, additional, Ogunjimi, Benson, additional, Tharwat, Samar, additional, Frediani, Bruno, additional, Maier, Armin, additional, Carubbi, Francesco, additional, Dagna, Lorenzo, additional, Erten, Sukran, additional, Gidaro, Antonio, additional, Hernández-Rodríguez, José, additional, Sfriso, Paolo, additional, Fabiani, Claudia, additional, Giacomelli, Roberto, additional, and Cantarini, Luca, additional

Published
2023
Full Text
View/download PDF

14. A disease to consider in the differential diagnosis of lower back pain: Celiac disease and related autoimmune disorders.

Author

Karakas, Ozlem, Armagan, Berkan, Kilic, Diler Tas, Ulusoy, Bahar Ozdemir, Atalar, Ebru, Koseoglu, Hasan Tankut, Yuksel, Mahmut, Kalkan, Cagdas, Akin, Fatma Ebru, Altiparmak, Emin, and Erten, Sukran

Subjects
CELIAC disease, LUMBAR pain, AUTOIMMUNE diseases, CONNECTIVE tissue diseases, SJOGREN'S syndrome, SYSTEMIC lupus erythematosus
Abstract

Introductıon: Celiac disease (CD) is an autoimmune disease caused by gluten ingestion in genetically susceptible individuals. Although gastrointestinal system symptoms are common, extraintestinal symptoms may be seen during the disease course. Due to similar genetic features and pathogenetic pathways for autoimmunity, increasing rheumatological diseases have been reported in CD in recent years. In this study, we aimed to evaluate patients with CD in terms of musculoskeletal symptomatology and presence of rheumatic disease and autoantibody positivity. Methods: The study was designed as a cross-sectional, retrospective cohort study. Between January 2020-2022, 65 patients with CD who were followed-up in the gastroenterology clinic of our hospital and consulted to the rheumatology outpatient clinic for any reason were included in the study. Medical records were reviewed, laboratory and imaging results were recorded. Results: Admission to the rheumatology clinic, the most common symptoms were inflammatory back pain(IBP) (43.1%) followed by xerophthalmia (15.4%). None of the patients with IBP had radiographically active sacroiliitis. In total, concomitant rheumatological diseases were 6 (9.2%): 2 patients (3.1%) had Sjögren's syndrome and one undifferentiated connective tissue disease, systemic lupus erythematosus, psoriatic arthritis and familial Mediterranean fever. Except for the CD autoantibodies, the frequency of anti-nuclear antibodies (ANA) was 38%, and the most common extractable nuclear antigen (ENA) patterns were DFS-70 and SSA. Conclusion: Although the most common symptom is IBP, the absence of radiographic findings of spondyloarthritis in CD patients suggests these to be a non-rheumatological cause associated with CD. On the other hand, CD patients with xerophthalmia and/or ANA positivity may need to be evaluated for connective tissue diseases, especially SjS. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

16. Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life

Author

Aydin, Sibel Zehra, Kucuksahin, Orhan, Kilic, Levent, Dogru, Atalay, Bayindir, Ozun, Ozisler, Cem, Omma, Ahmet, Tarhan, Emine Figen, Erden, Abdulsamet, Kimyon, Gezmis, Can, Meryem, Dalkilic, Ediz, Yavuz, Sule, Ureyen, Sibel Bakirci, Gunal, Esen Kasapoglu, Alhussain, Fatıma Arslan, Akyol, Lutfi, Balkarli, Ayse, Yilmaz, Sema, Cinar, Muhammet, Aydin, Muge Tufan, Solmaz, Dilek, Mercan, Ridvan, Erten, Sukran, and Kalyoncu, Umut

Published
2018
Full Text
View/download PDF

17. Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries

Author

Linde, Louise, primary, Ørnbjerg, Lykke M, additional, Georgiadis, Stylianos, additional, H. Rasmussen, Simon, additional, Lindström, Ulf, additional, Askling, Johan, additional, Michelsen, Brigitte, additional, Di Giuseppe, Daniela, additional, Wallman, Johan K, additional, Gudbjornsson, Bjorn, additional, Love, Thorvardur Jon, additional, Nordström, Dan C, additional, Yli-Kerttula, Timo, additional, Nekvindová, Lucie, additional, Vencovský, Jiří, additional, Iannone, Florenzo, additional, Cauli, Alberto, additional, Loft, Anne Gitte, additional, Glintborg, Bente, additional, Laas, Karin, additional, Rotar, Ziga, additional, Tomšič, Matija, additional, Macfarlane, Gary J, additional, Möller, Burkhard, additional, van de Sande, Marleen, additional, Codreanu, Catalin, additional, Nissen, Michael J, additional, Birlik, Merih, additional, Erten, Sukran, additional, Santos, Maria J, additional, Vieira-Sousa, Elsa, additional, Hetland, Merete L, additional, and Østergaard, Mikkel, additional

Published
2023
Full Text
View/download PDF

20. Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF-inhibitor: results from 13 European registries

Author

Linde, Louise, Ørnbjerg, Lykke M, Georgiadis, Stylianos, Rasmussen, Simon H, Lindström, Ulf, Askling, Johan, Michelsen, Brigitte, Di Giuseppe, Daniela, Wallman, Johan K, Gudbjornsson, Bjorn, Love, Thorvardur Jon, Nordström, Dan C, Yli-Kerttula, Timo, Nekvindová, Lucie, Vencovský, Jiří, Iannone, Florenzo, Cauli, Alberto, Loft, Anne Gitte, Glintborg, Bente, Laas, Karin, Rotar, Ziga, Tomšič, Matija, Macfarlane, Gary J, Möller, Burkhard, van de Sande, Marleen, Codreanu, Catalin, Nissen, Michael J, Birlik, Merih, Erten, Sukran, Santos, Maria J, Vieira-Sousa, Elsa, Hetland, Merete L, and Østergaard, Mikkel

Subjects
610 Medicine & health
Abstract

OBJECTIVES In bio-naïve patients with Psoriatic arthritis (PsA) initiating a Tumour Necrosis Factor inhibitor (TNFi), we aimed to identify baseline predictors of Disease Activity index for PsA in 28 joints (DAPSA28) remission (primary objective) and DAPSA28 moderate response at 6 months, as well as drug retention at 12 months across 13 European registries. METHODS Baseline demographic and clinical characteristics were retrieved and the three outcomes investigated per registry and in pooled data, using logistic regression analyses on multiply imputed data. In the pooled cohort, selected predictors that were either consistently positive or negative across all three outcomes, were defined as common predictors. RESULTS In the pooled cohort (n = 13 369), six-month proportions of remission, moderate response and 12-month drug retention were 25%, 34% and 63% in patients with available data (n = 6,954, n = 5,275 and n = 13 369, respectively). Baseline predictors of remission, moderate response and 12-month drug retention were identified, five common across all three outcomes. Odds ratios (95% confidence interval) for DAPSA28 remission were: age, per year: 0.97 (0.96-0.98); disease duration, years (< 2 years as reference): 2-3 years: 1.20 (0.89-1.60), 4-9 years: 1.42 (1.09-1.84), ≥10 years: 1.66 (1.26-2.20); men vs women: 1.85 (1.54-2.23); CRP >10 vs ≤ 10 mg/l: 1.52 (1.22-1.89) and one mm increase in patient fatigue score: 0.99 (0.98-0.99). CONCLUSION Baseline predictors of remission, response and adherence to TNFi were identified, of which five were common for all three outcomes, indicating that the predictors emerging from our pooled cohort may be considered generalisable from the country- to disease-level.

Published
2023
Full Text
View/download PDF

22. Vascular Involvement in Behcet's Disease: An Evaluation of 147 Cases and Literature Review.

Author

Atalar, Ebru, Erten, Sukran, Dogan, Ismail, and Konak, Hatice Ecem

Subjects
BEHCET'S disease, INFLAMMATION, ULTRASONIC imaging, MEDICAL care, THROMBOPHLEBITIS
Abstract

Objectives: Behcet's disease (BD) is characterized by systemic vasculitis with inflammation that can affect various body organs. In BD, vasculitis primarily manifests with venous involvement, distinguishing it from other forms of systemic vasculitis. Methods: We retrospectively analyzed the demographic and clinical characteristics of 147 patients diagnosed with vascular BD in our center. Results: Vascular BD cases accounted for 25.0% (147 out of 589) of all BD patients. A statistically significant correlation was found between gender and vascular involvement that was seen predominantly in males (76.9%). In 71 patients, a vascular event developed during follow-up for BD, while in 76 patients the disease was diagnosed after the occurrence of a vascular event (51.7%). The most common vascular event was deep vein thrombosis in the lower extremities (69.4%). Arterial involvement was primarily observed in the pulmonary arteries (12.9%). Patients with lower extremity deep vein thrombosis tended to be younger, while those with pulmonary artery involvement were typically older. Overall, veins were affected 4.5 times more frequently than arteries. Conclusion: The prevalent type of venous involvement was deep vein thrombosis in the lower extremities. Thrombotic events in BD cannot be solely attributed to abnormalities in thrombotic factors. The treatment of thrombotic events in BD remains contentious, with anticoagulant efficacy being debated and immunosuppressive therapy representing the primary treatment approach. Behcet's disease should be considered when a young male patient presents with an arterial or venous vascular event, especially if it is recurrent. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

26. Elevated Kynurenine Levels in Patients with Primary Sjögren's Syndrome.

Author

Apaydın, Hakan, Bicer, Cemile Koca, Yurt, Emine Feyza, Serdar, Muhittin Abdulkadir, Dogan, İsmail, and Erten, Sukran

Subjects
STATISTICS, LIQUID chromatography, MANN Whitney U Test, FISHER exact test, TRYPTOPHAN, COMPARATIVE studies, T-test (Statistics), MASS spectrometry, DESCRIPTIVE statistics, CHI-squared test, SJOGREN'S syndrome, DATA analysis software, DATA analysis, METABOLITES
Abstract

Objective We aimed to investigate the plasma levels of tryptophan (Trp) and its metabolites in patients with primary Sjögren's syndrome (pSS). Methods The study included 34 pSS patients and 42 healthy individuals, and serum Trp and kynurenine (Kyn) concentrations were measured by liquid chromatography with tandem mass spectrometry. Trp degradation was predicted using the ratio of Kyn and Trp concentrations (Kyn/Trp). Results In our study, the mean serum Trp concentration was found to be considerably lower in the pSS group than in the control group (P  = .001). The levels of Kyn (P  = .019) and the Kyn/Trp ratio (P  < .001) were significantly higher in the pSS group than in the control group. The Kyn/Trp ratio was negatively correlated with C-reactive protein (r = −0.369, P  = .032). Conclusion We found that Kyn pathway metabolism was altered in patients with pSS. This suggests that Trp metabolism may be closely linked to the disease pathogenesis of pSS. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

28. Real-world data on change in work productivity, activity impairment, and quality of life in patients with psoriatic arthritis under anti-TNF therapy: a postmarketing, noninterventional, observational study

Author

Karadag, Omer, primary, Dalkilic, Ediz, additional, Ayan, Gizem, additional, Kucuksahin, Orhan, additional, Kasifoglu, Timucin, additional, Yilmaz, Neslihan, additional, Koca, Suleyman Serdar, additional, Yazisiz, Veli, additional, Erten, Pinar Talu, additional, Sayarlioglu, Mehmet, additional, Terzioglu, Mustafa Ender, additional, Erten, Sukran, additional, and Kalyoncu, Umut, additional

Published
2021
Full Text
View/download PDF

29. Methodology of a new inflammatory arthritis registry: TReasure

Author

Tufan, Muge Aydin, Kalyoncu, Umut, Tascilar, Etem Koray, Ertenli, Ali Ihsan, Dalkilic, Huseyin Ediz, Bes, Cemal, Kucuksahin, Orhan, Kasifoglu, Timucin, Alpay Kanitez, Nilufer, Emmungil, Hakan, Kimyon, Gezmis, Yasar Bilge, Nafize Sule, Akar, Servet, Atagunduz, Mehmet Pamir, Koca, Suleyman Serdar, Ates, Askin, Yazisiz, Veli, Terzioglu, Ender, Ersozlu, Emine Duygu, Cinar, Muhammet, Mercan, Ridvan, Sahin, Ali, Erten, Sukran, Pehlivan, Yavuz, Yilmaz, Sedat, Kelesoglu Dincer, Ayse Bahar, Gercik, Onay, Coskun, Belkis Nihan, Yagiz, Burcu, Kaymaz Tahra, Sema, Aksoy, Aysun, Karadag, Omer, Kilic, Levent, Kiraz, Sedat, [Kalyoncu, Umut -- Ertenli, Ali Ihsan -- Karadag, Omer -- Kilic, Levent -- Kiraz, Sedat] Hacettepe Univ, Fac Med, Dept Internal Med, Div Rheumatol, Ankara, Turkey -- [Tascilar, Etem Koray] Okmeydani Training & Res Hosp, Rheumatol Clin, Istanbul, Turkey -- [Dalkilic, Huseyin Ediz -- Pehlivan, Yavuz -- Coskun, Belkis Nihan -- Yagiz, Burcu] Uludag Univ, Fac Med, Dept Internal Med, Div Rheumatol, Bursa, Turkey -- [Bes, Cemal -- Alpay Kanitez, Nilufer] Rheumatol Clin, Bakirkoy Dr Sadi Konuk Training & Res Hosp, Istanbul, Turkey -- [Kucuksahin, Orhan] Istinye Univ, Fac Med, Dept Internal Med, Div Rheumatol, Istanbul, Turkey -- [Kasifoglu, Timucin -- Yasar Bilge, Nazife Sule] Eskisehir Osmangazi Univ, Fac Med, Dept Internal Med, Div Rheumatol, Eskisehir, Turkey -- [Emmungil, Hakan] Trakya Univ, Fac Med, Dept Internal Med, Div Rheumatol, Edirne, Turkey -- [Kimyon, Gezmis] Mustafa Kemal Univ, Fac Med, Dept Internal Med, Div Rheumatol, Antakya, Turkey -- [Akar, Servet -- Gercik, Onay] Izmir Katip Celebi Univ, Fac Med, Dept Internal Med, Div Rheumatol, Izmir, Turkey -- [Atagunduz, Mehmet Pamir -- Kaymaz Tahra, Sema -- Aksoy, Aysun] Marmara Univ, Fac Med, Dept Internal Med, Div Rheumatol, Istanbul, Turkey -- [Koca, Suleyman Serdar] Firat Univ, Fac Med, Dept Internal Med, Div Rheumatol, Elazig, Turkey -- [Ates, Askin] Ankara Univ, Fac Med, Dept Internal Med, Div Rheumatol, Ankara, Turkey -- [Yazisiz, Veli -- Terzioglu, Ender] Akdeniz Univ, Fac Med, Dept Internal Med, Div Rheumatol, Antalya, Turkey -- [Ersozlu, Emine Duygu] Adana Numune Training & Res Hosp, Unit Rheumatol, Adana, Turkey -- [Tufan, Muge Aydin] Baskent Univ, Unit Rheumatol, Adana Hosp, Adana, Turkey -- [Cinar, Muhammet -- Yilmaz, Sedat] Univ Hlth Sci, Gulhane Fac Med, Dept Internal Med, Div Rheumatol, Ankara, Turkey -- [Mercan, Ridvan] Namik Kemal Univ, Fac Med, Dept Internal Med, Div Rheumatol, Tekirdag, Turkey -- [Sahin, Ali] Cumhuriyet Univ, Fac Med, Dept Internal Med, Div Rheumatol, Sivas, Turkey -- [Erten, SUkran] Yildirim Beyazit Univ, Fac Med, Dept Internal Med, Div Rheumatol, Ankara, Turkey, TASCILAR, Koray -- 0000-0002-8109-826X, Kaymaz-Tahra, Sema -- 0000-0001-5706-4943, Kalyoncu, Umut, Tascilar, Etem Koray, Ertenli, Ali Ihsan, Dalkilic, Huseyin Ediz, Bes, Cemal, Kucuksahin, Orhan, Kasifoglu, Timucin, Alpay Kanitez, Nilufer, Emmungil, Hakan, Kimyon, Gezmis, Yasar Bilge, Nazife Sule, Akar, Servet, Atagunduz, Mehmet Pamir, Koca, Suleyman Serdar, Ates, Askin, Yazisiz, Veli, Terzioglu, Ender, Ersozlu, Emine Duygu, Tufan, Muge Aydin, Cinar, Muhammet, Mercan, Ridvan, Sahin, Ali, Erten, SUkran, Pehlivan, Yavuz, Yilmaz, Sedat, Kelesoglu Dincer, Ayse Bahar, Gercik, Onay, Coskun, Belkis Nihan, Yagiz, Burcu, Kaymaz Tahra, Sema, Aksoy, Aysun, Karadag, Omer, Kilic, Levent, Kiraz, Sedat, İç Hastalıkları, İstinye Üniversitesi, Hastane, and Ege Üniversitesi

Subjects
Male, 0301 basic medicine, Turkey, Cross-sectional study, Inflammatory arthritis, NECROSIS FACTOR THERAPY, Datasets as Topic, Biologics Register, CLINICAL HISTORY, registry, DISEASE-ACTIVITY, Arthritis, Rheumatoid, Unique identifier, 0302 clinical medicine, Disease-Activity, Psoriatic-Arthritis, Health care, disease-modifying antirheumatic drugs, Necrosis Factor Therapy, Prospective Studies, Registries, Cerrahi, Rheumatoid-Arthritis, Clinical History, ANKYLOSING-SPONDYLITIS, General Medicine, Middle Aged, spondyloarthritis, BACK-PAIN, Antirheumatic Agents, Cohort, Society Classification Criteria, Female, Back-Pain, Treasure, medicine.medical_specialty, TReasure, Drug Industry, DIAGNOSTIC-CRITERIA, Ankylosing-Spondylitis, 03 medical and health sciences, Spondylarthritis, medicine, Humans, Rheumatoid arthritis, Diagnostic-Criteria, Aged, Retrospective Studies, business.industry, Retrospective cohort study, medicine.disease, RHEUMATOID-ARTHRITIS, Cross-Sectional Studies, 030104 developmental biology, Rheumatoid arthritis,spondyloarthritis,disease-modifying antirheumatic drugs,registry,TReasure, Family medicine, PSORIATIC-ARTHRITIS, BIOLOGICS REGISTER, 030221 ophthalmology & optometry, SOCIETY CLASSIFICATION CRITERIA, Observational study, Health Facilities, Societies, business
Abstract

WOS: 000441766000023, PubMed ID: 30119164, Background/aim: The TReasure registry, created in 2017, is an observational multicenter cohort that includes inflammatory arthritis patients. This article reviews the methodology and objectives of the TReasure registry established to collect data from rheumatoid arthritis (RA) and spondyloarthritis (SpA) patients. Methodology: Fifteen rheumatology centers in Turkey will contribute data to the TReasure database. The actual proprietor of the database is the Hacettepe Rheumatology Association (HRD) and Hacettepe Financial Enterprises. Pharmaceutical companies that operate in Turkey (in alphabetical or er), Abbvie, Amgen, BMS, Celltrion Healthcare, Novartis, Pfizer, Roche, and UCB, support the TReasure registry. TReasure is a web-based database to which users connect through a URL (https://www.trials-network.org/treasure) with their unique identifier and passwords provided for data entry and access. TReasure records demographic and clinical features, comorbidities, radiology and laboratory results, measures of disease activity, and treatment data. Discussion: TReasure will provide us with various types of data, such as a cross-sectional view of the current nationwide status of the patients currently receiving these treatments, and retrospective data as much as allowed by the participating centers' records. Finally, a high-quality prospective dataset will be built over the ensuing years from patients with a new diagnosis of RA or SpA.

Published
2018

31. Diagnostic dilemma of paraneoplastic arthritis: case series

Author

KISACIK, Bunyamin, ONAT, Ahmet M., KASIFOGLU, Timucin, PEHLIVAN, Yavuz, PAMUK, Omer N., DALKILIC, Ediz, DONMEZ, Salim, BILGE, Sule Y., YILMAZ, Sedat, ERDEM, Hakan, MERCAN, Ridvan, OZTURK, Mehmet A., BES, Cemal, SOY, Mehmet, ERTEN, Sukran, COBANKARA, Veli, SENEL, Soner, ONER, Fatma A., DIRESKENELI, Haner, YILMAZ, Sema, YAZICI, Ayten, EMMUNGIL, Hakan, AKSU, Kenan, KUL, Seval, CETIN, Gozde Y., and SAYARLIOGLU, Mehmet

Published
2014
Full Text
View/download PDF

32. Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study

Author

Kasifoglu, Timucin, Bilge, Sule Yasar, Sari, Ismail, Solmaz, Dilek, Senel, Soner, Emmungil, Hakan, Kilic, Levent, Oner, Sibel Yilmaz, Yildiz, Fatih, Yilmaz, Sedat, Bakirli, Duygu Ersozlu, Tufan, Muge Aydin, Yilmaz, Sema, Yazisiz, Veli, Pehlivan, Yavuz, Bes, Cemal, Cetin, Gozde Yildirim, Erten, Sukran, Gonullu, Emel, Temel, Tuncer, Sahin, Fezan, Akar, Servet, Aksu, Kenan, Kalyoncu, Umut, Direskeneli, Haner, Erken, Eren, Kisacik, Bunyamin, Sayarlioglu, Mehmet, and Korkmaz, Cengiz

Published
2014
Full Text
View/download PDF

41. Corticosteroid Utilization before and after Initiation of Biologic Dmards between Patients with Rheumatoid Arthritis

Author

Yagiz, Burcu, Coskun, Belkis Nihan, Kiraz, Sedat, Ertenli, Ihsan, Kucuksahin, Orhan, Dalkilic, Ediz, Bes, Cemal, Kanitez, Nilufer Alpay, Kasifoglu, Timucin, Emmungil, Hakan, Atagunduz, Pamir, Koca, Suleyman Serdar, Cinar, Muhammet, Ates, Askin, Akar, Servet, Gercik, Onay, Bakirli, Duygu Ersozlu, Yazisiz, Veli, Kimyon, Gezmis, Bilge, Nazife Sule Yasar, Muge Aydin Tufan, Mercan, Ridvan, Oz, Burak, Akar, Zeynel Abidin, Karadag, Omer, Kelesoglu, Bahar, Yilmaz, Sedat, Turan, Sezin, Pehlivan, Yavuz, Terzioglu, Ender, Kilic, Levent, Erten, Sukran, Tascilar, Koray, and Kalyoncu, Umut

Published
2018

42. AB0723 SMOKING MAY BE RELATED TO SACROILIITIS IN ENTEROPATHIC ARTHRITIS PATIENTS: TREASURE REAL-LIFE PRELIMINARY DATA

Author

Küçükşahin, Orhan, primary, Erden, Abdulsamet, additional, İlgen, Ufuk, additional, Kiraz, Sedat, additional, Ertenli, Ali İhsan, additional, Yasar Bilge, Nazife Sule, additional, Kaşifoğlu, Timuçin, additional, Dalkılıç, Ediz, additional, Bes, Cemal, additional, Kanıtez, Nilüfer alpay, additional, Emmungil, Hakan, additional, Atagündüz, Pamir, additional, Seniz, Belkis Nihan, additional, Yağız, Burcu, additional, Koca, Süleyman Serdar, additional, Çınar, Muhammet, additional, Ateş, Aşkın, additional, Akar, Servet, additional, Gerçik, Önay, additional, Ersözlü, Duygu, additional, Yazısız, Veli, additional, Kimyon, Gezmiş, additional, Aydın, Müge, additional, Mercan, Rıdvan, additional, Öz, Burak, additional, Akar, Zeynel abidin, additional, Karadag, Omer, additional, Keleşoğlu, Bahar, additional, Yılmaz, Sedat, additional, Pehlivan, Yavuz, additional, Terzioğlu, Ender, additional, Kılıç, Levent, additional, Erten, Sukran, additional, Taşçılar, Koray, additional, and Kalyoncu, Umut, additional

Published
2019
Full Text
View/download PDF

43. THU0410 UVEITIS RELATED FACTORS IN PATIENTS WITH SPONDYLOARTHRITIS

Author

Yasar Bilge, Nazife Sule, primary, Kaşifoğlu, Timuçin, additional, Kiraz, Sedat, additional, Ertenli, Ali İhsan, additional, Küçükşahin, Orhan, additional, Dalkılıç, Ediz, additional, Bes, Cemal, additional, Kanıtez, Nilüfer Alpay, additional, Emmungil, Hakan, additional, Atagunduz, Pamir, additional, Seniz, Belkis Nihan, additional, Yağız, Burcu, additional, Koca, Süleyman Serdar, additional, Çınar, Muhammet, additional, Ateş, Aşkın, additional, Akar, Servet, additional, Ersözlü, Duygu, additional, Yazisiz, Veli, additional, Kimyon, Gezmiş, additional, Tufan, Muge Aydın, additional, Mercan, Ridvan, additional, Erden, Abdulsamet, additional, Bodakci, Erdal, additional, Gerçik, Önay, additional, Öz, Burak, additional, Akar, Zeynel Abidin, additional, Karadag, Omer, additional, Dincer, Bahar, additional, Yılmaz, Sedat, additional, Pehlivan, Yavuz, additional, Terzioğlu, Ender, additional, Kılıç, Levent, additional, Gönüllü, Emel, additional, Erten, Sukran, additional, Turan, Sezin, additional, Taşçılar, Koray, additional, and Kalyoncu, Umut, additional

Published
2019
Full Text
View/download PDF

46. The Disease Course in Daily Clinical Practice in Radiographic and Non-Radiographic Axial Spondyloarthritis Patients; One-Year Follow-up Results of National-Subgroup of a Worldwide Observational Cohort Study

Author

Akar, Servet, Sezer, Ilhan, Yumusakhuylu, Yasemin, Akinci, Aysen, Erol, Kemal, Akgun, Kenan, Bodur, Hatice, Ataman, Sebnem, Kuru, Omer, Meltem Alkan Melikoglu, Karkucak, Murat, Bugdayci, Nazli Derya, Bakirli, Duygu Ersozlu, Birtane, Murat, Duruoz, Tuncay, Erten, Sukran, Dalkilic, Ediz, Kinikli, Gulay, Bes, Cemal, Omma, Ahmet, Rezvani, Aylin, and REZVANİ, AYLİN

Subjects
AKAR S., Sezer I., Yumusakhuylu Y., AKINCI A., Erol K., Akgun K., Bodur H., Ataman S., Kuru O., ALKAN MELİKOĞLU M., et al., -The Disease Course in Daily Clinical Practice in Radiographic and Non-Radiographic Axial Spondyloarthritis Patients, One-Year Follow-up Results of National-Subgroup of a Worldwide Observational Cohort Study-, ARTHRITIS & RHEUMATOLOGY, cilt.69, 2017
Published
2017

48. Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients

Author

Akar, Servet, primary, Cetin, Pınar, additional, Kalyoncu, Umut, additional, Karadag, Omer, additional, Sari, Ismail, additional, Cınar, Muhammed, additional, Yilmaz, Sedat, additional, Onat, Ahmet Mesut, additional, Kisacik, Bunyamin, additional, Erden, Abdulsamet, additional, Balkarli, Ayse, additional, Kucuksahin, Orhan, additional, Oner, Sibel Yilmaz, additional, Senel, Soner, additional, Tufan, Abdurrahman, additional, Direskeneli, Haner, additional, Oksuz, Ferhat, additional, Pehlivan, Yavuz, additional, Bayindir, Ozun, additional, Keser, Gokhan, additional, Aksu, Kenan, additional, Omma, Ahmet, additional, Kasifoglu, Timucin, additional, Unal, Ali Ugur, additional, Yildiz, Fatih, additional, Balci, Mehmet Ali, additional, Yavuz, Sule, additional, Erten, Sukran, additional, Ozgen, Metin, additional, Sayarlıoglu, Mehmet, additional, Dogru, Atalay, additional, Yildirim, Gozde, additional, Oner, Fatma Alibaz, additional, Tezcan, Mehmet Engin, additional, Pamuk, Omer Nuri, additional, and Onen, Fatos, additional

Published
2018
Full Text
View/download PDF

50. Comparison of early versus late onset familial Mediterranean fever

Author

Yasar Bilge, Nazife Sule, primary, Sari, Ismail, additional, Solmaz, Dilek, additional, Senel, Soner, additional, Emmungil, Hakan, additional, Kilic, Levent, additional, Yilmaz Oner, Sibel, additional, Yildiz, Fatih, additional, Yilmaz, Sedat, additional, Ersozlu Bozkirli, Duygu, additional, Aydin Tufan, Muge, additional, Yilmaz, Sema, additional, Yazisiz, Veli, additional, Pehlivan, Yavuz, additional, Bes, Cemal, additional, Yildirim Cetin, Gozde, additional, Erten, Sukran, additional, Gonullu, Emel, additional, Sahin, Fezan, additional, Akar, Servet, additional, Aksu, Kenan, additional, Kalyoncu, Umut, additional, Direskeneli, Haner, additional, Erken, Eren, additional, Sayarlioglu, Mehmet, additional, Cınar, Muhammed, additional, and Kasifoglu, Timucin, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results